Tanja Kortemme, PhD, is a Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California San Francisco (UCSF) and a Chan Zuckerberg Biohub Investigator. Her group develops foundational computational approaches to design proteins de novo, and applies these methods to engineer new functions across biological scales, ranging from atomic details of macromolecular interactions to cellular processes. Dr. Kortemme received her PhD (Dr. rer. nat.) in Biochemistry and Biophysics from EMBL Heidelberg and the University of Hannover, Germany, and conducted research as an EMBO and Human Frontier Science Program Fellow at the University of Washington Seattle. She is a recipient of an NSF CAREER award, a Sloan Foundation award in Molecular Biology, and an elected Fellow of the American Institute for Medical and Biological Engineering.